第九届董事会第三十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：600186 证券简称：莲花控股 公告编号：2025-060 莲花控股股份有限公司 莲花控股股份有限公司（以下简称"公司"）第九届董事会第三十三次会议 通知于 2025 年 8 月 18 日发出，于 2025 年 8 月 28 日以现场和通讯相结合的方式 召开。本次会议应出席董事 11 人，实际出席董事 11 人。会议由董事长李厚文先 生主持，现场会议在公司会议室召开，会议的召开符合《公司法》及《公司章程》 的有关规定。会议审议并表决通过了以下议案： 一、审议通过《2025 年半年度报告全文及摘要》 具体详见公司于同日在指定信息披露媒体披露的《2025 年半年度报告》及 《2025 年半年度报告摘要》。 本议案已经董事会审计委员会审议通过，同意提交董事会审议。 表决结果：同意 11 票，反对 0 票，弃权 0 票。 二、审议通过《2025 年上半年度募集资金存放与使用情况的专项报告》 具体详见公司于同日在指定信息披露媒体披露的《关于 ...

苏州迈为科技股份有限公司 信息披露暂缓与豁免制度 第一章 总 则 第一条 为规范苏州迈为科技股份有限公司（以下简称"公司"）信息披露暂 缓与豁免行为，确保公司及相关信息披露义务人（以下简称"信息披露义务人"） 依法合规地履行信息披露义务，保护投资者的合法权益，根据《中华人民共和国 公司法》 《中华人民共和国证券法》 《上市公司信息披露暂缓与豁免管理规定》 《深 圳证券交易所创业板股票上市规则》 （以下简称"《股票上市规则》"）以及有关法 律、法规、规章和《苏州迈为科技股份有限公司章程》 （以下简称" 《公司章程》"）、 第五条 公司和其他信息披露义务人有确实充分的证据证明拟披露的信息涉 及国家秘密或者其他因披露可能导致违反国家保密规定、管理要求的事项（以下 统称"国家秘密"），依法豁免披露。 第六条 公司和其他信息披露义务人有保守国家秘密的义务，不得通过信息 披露、投资者互动问答、新闻发布、接受采访等任何形式泄露国家秘密，不得以 信息涉密为名进行业务宣传。 公司的董事长、董事会秘书应当增强保守国家秘密的法律意识，保证所披露 的信息不违反国家保密规定。 第七条 公司和其他信息披露义务人拟披露的信息涉及商业秘密或 ...

Core Points - The document outlines the information disclosure deferral and exemption system for Guangdong Shenglu Communication Technology Co., Ltd, ensuring compliance with relevant laws and regulations while protecting investors' rights [1][8] - The company and other obligated parties must carefully determine deferral and exemption matters, following internal review procedures before implementation [3][5] Group 1: General Provisions - The system is established to regulate the deferral and exemption of information disclosure, ensuring compliance with the Company Law, Securities Law, and relevant stock exchange rules [1] - The company must disclose information accurately, completely, and timely, without abusing deferral or exemption to mislead investors [1][2] Group 2: Scope and Methods of Deferral and Exemption - Information can be deferred or exempted if it involves state secrets or commercial secrets that could lead to unfair competition or harm to the company or others [2][6] - The company can use aliases, summaries, or omit key information in periodic reports if it involves state or commercial secrets [3][6] Group 3: Internal Review Procedures - Departments or subsidiaries must submit an application for deferral or exemption, ensuring the accuracy and completeness of the submitted materials [5][6] - The company must maintain records of deferral and exemption matters, including the type of documents and internal review procedures [6][7] Group 4: Accountability - The company has established a responsibility accountability mechanism for failing to report deferral or exemption matters in a timely manner, which may lead to negative impacts on the company and investors [7][8] Group 5: Miscellaneous - The system will take effect upon approval by the board of directors and must comply with relevant stock exchange rules and national laws [8][8]

Group 1 - The board of directors of Beijing Sunshine Nuohua Pharmaceutical Research Co., Ltd. held a meeting where all 9 directors attended, complying with relevant laws and regulations [1][2] - The board unanimously approved the proposal for the initial grant of restricted stock under the 2025 Restricted Stock Incentive Plan, with a grant date of June 11, 2025, and a grant price of 22.78 yuan per share for 1,277,428 shares to 127 eligible recipients [1][2] - The board also approved the addition of the "Information Disclosure Postponement and Exemption System" to regulate the company's information disclosure practices, ensuring compliance with various legal and regulatory requirements [2]